Skip to Content
Merck
All Photos(1)

Key Documents

87890

Sigma-Aldrich

N,N,N′,N′-Tetramethyl-p-phenylenediamine dihydrochloride

≥97.0% (AT)

Synonym(s):

TMPPD, Wurster’s reagent

Sign Into View Organizational & Contract Pricing


About This Item

Linear Formula:
C6H4[N(CH3)2]2·2HCl
CAS Number:
Molecular Weight:
237.17
Beilstein:
7442241
EC Number:
MDL number:
UNSPSC Code:
12352100
PubChem Substance ID:
NACRES:
NA.22

Quality Level

Assay

≥97.0% (AT)

form

powder

mp

222-224 °C (lit.)

SMILES string

Cl[H].Cl[H].CN(C)c1ccc(cc1)N(C)C

InChI

1S/C10H16N2.2ClH/c1-11(2)9-5-7-10(8-6-9)12(3)4;;/h5-8H,1-4H3;2*1H

InChI key

FBHKTSXMTASXFJ-UHFFFAOYSA-N

Looking for similar products? Visit Product Comparison Guide

Application

Test reagent in microbiology for the classification of cytochrome oxidase positive aerobic microorganisms.; For oxidase reagent, use a 1% aqueous solution of N,N,N′,N′-Tetramethyl-p-phenylenediamine dihydrochloride

Pictograms

Exclamation mark

Signal Word

Warning

Hazard Statements

Hazard Classifications

Eye Irrit. 2 - Skin Irrit. 2

Storage Class Code

11 - Combustible Solids

WGK

WGK 3

Flash Point(F)

Not applicable

Flash Point(C)

Not applicable

Personal Protective Equipment

dust mask type N95 (US), Eyeshields, Gloves

Choose from one of the most recent versions:

Certificates of Analysis (COA)

Lot/Batch Number

Don't see the Right Version?

If you require a particular version, you can look up a specific certificate by the Lot or Batch number.

Already Own This Product?

Find documentation for the products that you have recently purchased in the Document Library.

Visit the Document Library

Lija Swain et al.
Journal of the American College of Cardiology, 76(6), 684-699 (2020-08-09)
Myocardial damage due to acute ST-segment elevation myocardial infarction (STEMI) remains a significant global health problem. New approaches to limit myocardial infarct size and reduce progression to heart failure after STEMI are needed. Mechanically reducing left ventricular (LV) workload (LV unloading)
Hélène Pelicano et al.
Breast cancer research : BCR, 16(5), 434-434 (2014-09-12)
Triple-negative breast cancer (TNBC) is a subtype of highly malignant breast cancer with poor prognosis. TNBC is not amenable to endocrine therapy and often exhibit resistance to current chemotherapeutic agents, therefore, further understanding of the biological properties of these cancer

Our team of scientists has experience in all areas of research including Life Science, Material Science, Chemical Synthesis, Chromatography, Analytical and many others.

Contact Technical Service